Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05643235 · ClinicalTrials.gov registry record · NA
Implanted Loop Recorders for Detection and Management of Arrhythmia With Bruton Tyrosine Kinase Inhibitors
A NA study of Atrial Fibrillation and Chronic Lymphocytic Leukemia, sponsored by Northwell Health.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT05643235 is a NA study of Atrial Fibrillation and Chronic Lymphocytic Leukemia that is actively recruiting participants, run by Northwell Health. The registered enrollment target is 50 participants, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05643235, a NA study of Atrial Fibrillation and Chronic Lymphocytic Leukemia, is actively recruiting participants, sponsored by Northwell Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will enroll patients initiating Bruton Tyrosine Kinase (BTK) inhibitors without history of documented arrhythmia while on therapy using the Medtronic LINQ-2 insertable cardiac monitor (ILR). The incidence of new onset atrial fibrillation (AF) and other arrhythmia will be determined. Actions taken in response to device detected arrhythmia will be recorded.
Conditions Studied
Interventions
- DEVICE Medtronic LINQ-2 Insertable Cardiac Monitor (ILR)
Study Locations (1)
New York
- Northwell (Northshore University/Long Island Jewish Hospitals) - New Hyde Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-01-01 |
| Est. Completion | 2030-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05643235
The ClinicalTrials.gov registry entry for NCT05643235 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (98% lower). The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which Medtronic LINQ-2 Insertable Cardiac Monitor (ILR) is the first listed.
NCT05643235 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT05643235 about?
NCT05643235 is a clinical study titled "Implanted Loop Recorders for Detection and Management of Arrhythmia With Bruton Tyrosine Kinase Inhibitors". This study will enroll patients initiating Bruton Tyrosine Kinase (BTK) inhibitors without history of documented arrhythmia while on therapy using the Medtronic LINQ-2 insertable cardiac monitor (ILR). The incidence of new onset atrial fibrillation (AF) and other arrhythmia will be determined. Actio...
What is the current status of trial NCT05643235?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2023-01-01. Estimated completion is 2030-12-01.
What conditions does trial NCT05643235 study?
This clinical trial studies the following conditions: Atrial Fibrillation, Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Supraventricular Arrhythmia, Ventricular Arrhythmias and Cardiac Arrest.
What interventions are being tested in trial NCT05643235?
The interventions under investigation include: Medtronic LINQ-2 Insertable Cardiac Monitor (ILR) (DEVICE).
Who is sponsoring clinical trial NCT05643235?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05643235 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Renal Denervation + PVI vs PVI Alone for Persistent AF
RECRUITING · NA
-
Pericardiotomy in Cardiac Surgery
RECRUITING · NA
-
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
RECRUITING · NA
-
The CONFORM Pivotal Trial
RECRUITING · NA
-
Vascular Closure With a Device Compared to Manual Compression After Atrial Fibrillation Ablation: The LockeT II Study
RECRUITING · NA
-
The Fourth Left Atrial Appendage Occlusion Study
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.